Close Menu

NEW YORK – Shares of transplant diagnostics company CareDx's stock rose more than 11 percent in Thursday morning trading on the Nasdaq after the company said that it had received a final local coverage determination from Medicare contractor Palmetto GBA for its AlloSure Heart test.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.